An Evidence-Based Perspective Key Points GLP-1 medications are safe from a psychiatric perspective and dont increase risk of depression or suicidality These medications improve mental health-related quality of life and eating behaviors beyond their effects on weight Lower doses combined with comprehensive psychological and lifestyle support produce excellent results with minimal side effects GLP-1s reduce inflammation, which directly benefits mood and neurotransmitter function Psychiatrists are well-positioned to prescribe GLP-1s as part of integrated metabolic-psychiatric care I want to address a question that comes up constantly in psychiatric circles right now
Retatrutide side effects are real, and fatigue ranks among the most commonly reported complaints in clinical trial participants
1 A separate two-year extension followed participants with a BMI of 35 or higher who completed the main trial and tolerated their dose
These trends are expected to have a material impact on a number of non-health industries, with some benefiting and others disadvantaged, although there is a lack of consensus on the scale and timing of the impact
If you have two hands and can do it, you can stabilize the needle with one hand or you can just move your finger back and push all the medication in at a slow, steady rate
Pancreatic proglucagon gene expression is promoted upon fasting and hypoglycaemia induction and inhibited by insulin